Form 4 for KTTA Pasithea Therapeutics Corp.
Accepted 2022-10-19 00:00:00 ET · period of report 2022-10-17 · accession 0001209191-22-054100 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-10-19 | 2022-10-17 | KTTA | Delaney David | Member of 10% owner group | P - Purchase | $1.11 | +1,000 | 227.5K | +0.4% | +$1,110 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-17 | P | A | 1,000 | $1.11 | 227,521 | I See footnote | — | — | (F1) The shares were purchased by Elderhill Corporation, of which David Delaney serves as sole director and President. (F2) 191,321 shares are held by Concord IP2, Ltd., of which David Delaney serves as sole director and President, and 36,200 shares are held by Elderhill Corporation. |